SIGB Trademark

Trademark Overview


On Wednesday, August 17, 2022, a trademark application was filed for SIGB with the United States Patent and Trademark Office. The USPTO has given the SIGB trademark a serial number of 79355106. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, January 22, 2024. This trademark is owned by Bonays Biomedical Technology (Shanghai)Co., Ltd.. The SIGB trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for suppressing tumors; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immune system related diseases and disorders; immunostimulants; medicinal preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations for the treatment of immune system related diseases and disorders; chemical reagents for medical purposes; hormones for medical purposes; biological tissue cultures for medical purposes

Scientific research; medical and scientific research in the field of cancer treatment; research and development in the field of cancer treatment; scientific laboratory services; biological research; medical and scientific research, namely, conducting clinical trials for others; medical research; material testing; chemical analysis; bacteriological research
sigb

General Information


Serial Number79355106
Word MarkSIGB
Filing DateWednesday, August 17, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, January 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDiagnostic biomarker reagents for medical purposes; pharmaceutical preparations for suppressing tumors; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immune system related diseases and disorders; immunostimulants; medicinal preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations for the treatment of immune system related diseases and disorders; chemical reagents for medical purposes; hormones for medical purposes; biological tissue cultures for medical purposes
Pseudo MarkSIGBEE SIG B SIG BE SIG BEE
Goods and ServicesScientific research; medical and scientific research in the field of cancer treatment; research and development in the field of cancer treatment; scientific laboratory services; biological research; medical and scientific research, namely, conducting clinical trials for others; medical research; material testing; chemical analysis; bacteriological research

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 22, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBonays Biomedical Technology (Shanghai)Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCN

Trademark Events


Event DateEvent Description
Wednesday, April 10, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 10, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, January 22, 2024ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, January 22, 2024ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, January 22, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, August 1, 2023REFUSAL PROCESSED BY IB
Tuesday, July 11, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, July 10, 2023REFUSAL PROCESSED BY MPU
Tuesday, June 6, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 5, 2023NON-FINAL ACTION WRITTEN
Monday, June 5, 2023ASSIGNED TO EXAMINER
Saturday, November 26, 2022APPLICATION FILING RECEIPT MAILED
Tuesday, November 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 18, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, November 10, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB